Multi-drug resistant Clostridioides difficile isolate ST81 is prominent in hematological patients in a teaching hospital in China
Frontiers in Cellular and Infection Microbiology · 2025
DOI: 10.3389/fcimb.2025.1668584 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Qi Zhao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory MedIcine, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, China. Hauptthemen laut MEDLINE: Clostridium Infections, Clostridioides difficile, Drug Resistance, Multiple, Bacterial, Hematologic Diseases. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Clostridioides difficile Infection (CDI) is more prevalent in people with hematologic diseases. However, epidemiological characteristics are poorly understood.
Methods
From July 2016 to November 2021, we studied the epidemiology of CDI in patients with hematological diseases at a tertiary teaching hospital in Shanghai, China.
Results
In hematological patients, the prevalence of CDI was 21.6%, with 89.8% hospital-acquired infections. C. difficile ST81, which is a multidrug-resistant strain carrying only the toxin B, is the most common strain (38.1%), followed by ST3 (16.7%) and ST2 (9.5%). Clindamycin and moxifloxacin resistance rates of all C. difficile species were 64.3% and 31%, respectively, and no isolate was resistant to vancomycin, linezolid, metronidazole, teicoplanin, or daptomycin.
Discussion
This study provides a comprehensive characterization of CDI in hematological patients, highlighting the urgent need for enhanced surveillance and preventive strategies against this emerging nosocomial threat.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory MedIcine, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, China.
- Department of Laboratory Medicine, Dachang Hospital of Baoshan District of Shanghai, Shanghai, China.
- Department of Laboratory Medicine, The Eighth People's Hospital of Qingdao, Qindao, China.
- Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- College of Health Science and Technology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zitieren
APA
Zhao, Q., Bian, Y., Wei, X., Xiao, S., Xu, Z., Li, H., Li, Q., Wei, B., Huang, J., Song, Z., & Zhao, Y. (2025). Multi-drug resistant Clostridioides difficile isolate ST81 is prominent in hematological patients in a teaching hospital in China. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1668584
Vancouver
Zhao Q, Bian Y, Wei X, Xiao S, Xu Z, Li H, et al. Multi-drug resistant Clostridioides difficile isolate ST81 is prominent in hematological patients in a teaching hospital in China. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1668584
BibTeX
@article{Zhao2025,
author = {Zhao, Qi and Bian, YaoQian and Wei, XinJun and Xiao, Shuzhen and Xu, Zizhen and Li, Hui and Li, Qingtian and Wei, Beiwen and Huang, Jiewen and Song, Zhen and Zhao, Yanan},
title = {Multi-drug resistant Clostridioides difficile isolate ST81 is prominent in hematological patients in a teaching hospital in China},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2025},
doi = {10.3389/fcimb.2025.1668584}
}
EUVIMED